Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2017 | ImMAGE Biotherapeutics Announces Termination of Operations | CI |
2017 | ImMAGE Biotherapeutics Initiates Repeat Toxicology Study for Lead Candidate, IMT-001 | CI |
Business Summary
Number of employees: 4
Sales per Business
USD in Million | 2016 | Weight | Delta |
---|---|---|---|
Cancer Immunotherapy
nan
%
| 0 | nan % | - |
Sales per region
USD in Million | 2016 | Weight | Delta |
---|---|---|---|
United States
nan
%
| 0 | nan % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Narayanan
FOU | Founder | 35 | 12-06-20 |
Anton Dormer
FOU | Founder | 60 | 12-06-20 |
Zhi Cong Mou
CEO | Chief Executive Officer | 41 | - |
Elton Norman
DFI | Director of Finance/CFO | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Cong Mou
CEO | Chief Executive Officer | 41 | - |
Elton Norman
DFI | Director of Finance/CFO | 61 | - |
Anton Dormer
FOU | Founder | 60 | 12-06-20 |
Mahesh Narayanan
FOU | Founder | 35 | 12-06-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 151,744,566 | 45,742,136 ( 30.14 %) | 0 | 30.14 % |
Company contact information
Immage Biotherapeutics Corp.
10411 Motor City Drive Suite 750
20817, Bethesda
+866 692 2939
1st Jan change | Capi. | |
---|---|---|
-.--% | 151 | |
+5.62% | 105B | |
-3.23% | 63.99B | |
+53.33% | 42.95B | |
+17.94% | 39.2B | |
+6.56% | 33.01B | |
+11.65% | 20.33B | |
+14.15% | 17.29B | |
+24.53% | 15.72B | |
+7.25% | 14.72B |
- Stock Market
- Equities
- IMMG Stock
- Company Immage Biotherapeutics Corp.